Related references
Note: Only part of the references are listed.Innovation in regulatory approaches for endocrine disrupting chemicals: The journey to risk assessment modernization in Canada
T. S. Barton-Maclaren et al.
ENVIRONMENTAL RESEARCH (2022)
Canadian Regulatory Perspective on Next Generation Risk Assessments for Pest Control Products and Industrial Chemicals
Yadvinder Bhuller et al.
FRONTIERS IN TOXICOLOGY (2021)
Hazard identification, classification, and risk assessment of carcinogens: too much or too little? - Report of an ECETOC workshop
Susan P. Felter et al.
CRITICAL REVIEWS IN TOXICOLOGY (2020)
A cross-sector call to improve carcinogenicity risk assessment through use of genomic methodologies
Carole L. Yauk et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2020)
An evaluation framework for new approach methodologies (NAMs) for human health safety assessment
Stanley T. Parish et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2020)
Chemical carcinogen safety testing: OECD expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens
Miriam N. Jacobs et al.
ARCHIVES OF TOXICOLOGY (2020)
Short-term toxicogenomics as an alternative approach to chronic in vivo studies for derivation of points of departure: A case study in the rat with a triazole fungicide
Jessica LaRocca et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2020)
A comprehensive view on mechanistic approaches for cancer risk assessment of non-genotoxic agrochemicals
Mirjam Luijten et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2020)
Internationalization of Read-Across as a Validated New Approach Method (NAM) for Regulatory Toxicology
Costanza Rovida et al.
ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION (2020)
A simple problem formulation framework to create the right solution to the right problem
Alaina Sauve-Ciencewicki et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2019)
Towards grouping concepts based on new approach methodologies in chemical hazard assessment: the read-across approach of the EU-ToxRisk project
Sylvia E. Escher et al.
ARCHIVES OF TOXICOLOGY (2019)
Reducing the need for animal testing while increasing efficiency in a pesticide regulatory setting: Lessons from the EPA Office of Pesticide Programs' Hazard and Science Policy Council
Evisabel Craig et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2019)
Chemical carcinogenicity revisited 2: Current knowledge of carcinogenesis shows that categorization as a carcinogen or non-carcinogen is not scientifically credible
John E. Doe et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2019)
Chemical carcinogenicity revisited 1: A unified theory of carcinogenicity based on contemporary knowledge
Douglas C. Wolf et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2019)
Chemical carcinogenicity revisited 3: Risk assessment of carcinogenic potential based on the current state of knowledge of carcinogenesis in humans
Samuel M. Cohen et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2019)
The Changing Epidemiology of Posttransplant Lymphoproliferative Disorder in Adult Solid Organ Transplant Recipients Over 30 Years: A Single-center Experience
Anthea C. Peters et al.
TRANSPLANTATION (2018)
The PPAR alpha-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions
J. Christopher Corton et al.
ARCHIVES OF TOXICOLOGY (2018)
Moving forward in carcinogenicity assessment: Report of an EURL ECVAM/ESTIV workshop
Raffaella Corvi et al.
TOXICOLOGY IN VITRO (2017)
An integrative test strategy for cancer hazard identification
Mirjam Luijten et al.
CRITICAL REVIEWS IN TOXICOLOGY (2016)
Critical analysis of carcinogenicity study outcomes. Relationship with pharmacological properties
Jan Willem van der Laan et al.
CRITICAL REVIEWS IN TOXICOLOGY (2016)
Classification schemes for carcinogenicity based on hazard - identification have become outmoded and serve neither science nor society
Alan R. Boobis et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2016)
A strategy for structuring and reporting a read-across prediction of toxicity
T. W. Schultz et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2015)
Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis
Teresa A. Simon et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Mode of action and dose-response framework analysis for receptor-mediated toxicity: The aryl hydrocarbon receptor as a case study
R. A. Budinsky et al.
CRITICAL REVIEWS IN TOXICOLOGY (2014)
Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: A case study with phenobarbital as a model constitutive androstane receptor (CAR) activator
Clifford R. Elcombe et al.
CRITICAL REVIEWS IN TOXICOLOGY (2014)
Mode-of-action and human relevance framework analysis for rat Leydig cell tumors associated with sulfoxaflor
Reza J. Rasoulpour et al.
CRITICAL REVIEWS IN TOXICOLOGY (2014)
Risk assessment in the 21st century: Roadmap and matrix
Michelle R. Embry et al.
CRITICAL REVIEWS IN TOXICOLOGY (2014)
A 21st century roadmap for human health risk assessment
Timothy P. Pastoor et al.
CRITICAL REVIEWS IN TOXICOLOGY (2014)
The use of mode of action information in risk assessment: Quantitative key events/dose-response framework for modeling the dose-response for key events
Ted W. Simon et al.
CRITICAL REVIEWS IN TOXICOLOGY (2014)
New developments in the evolution and application of the WHO/IPCS framework on mode of action/species concordance analysis
M. E. Meek et al.
JOURNAL OF APPLIED TOXICOLOGY (2014)
Dose-Response Modeling of Early Molecular and Cellular Key Events in the CAR-Mediated Hepatocarcinogenesis Pathway
David R. Geter et al.
TOXICOLOGICAL SCIENCES (2014)
Food for Thought ... Read-Across Approaches - Misconceptions, Promises and Challenges Ahead
Grace Patlewicz et al.
ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION (2014)
Concordance of Transcriptional and Apical Benchmark Dose Levels for Conazole-Induced Liver Effects in Mice
Virunya S. Bhat et al.
TOXICOLOGICAL SCIENCES (2013)
Incorporating New Technologies Into Toxicity Testing and Risk Assessment: Moving From 21st Century Vision to a Data-Driven Framework
Russell S. Thomas et al.
TOXICOLOGICAL SCIENCES (2013)
An Analysis of Pharmaceutical Experience with Decades of Rat Carcinogenicity Testing: Support for a Proposal to Modify Current Regulatory Guidelines
Frank D. Sistare et al.
TOXICOLOGIC PATHOLOGY (2011)
The mouse carcinogenicity study is no longer a scientifically justifiable core data requirement for the safety assessment of pesticides
Richard Billington et al.
CRITICAL REVIEWS IN TOXICOLOGY (2010)
ADVERSE OUTCOME PATHWAYS: A CONCEPTUAL FRAMEWORK TO SUPPORT ECOTOXICOLOGY RESEARCH AND RISK ASSESSMENT
Gerald T. Ankley et al.
ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY (2010)
Critical Review of Preclinical Approaches to Evaluate the Potential of Immunosuppressive Drugs to Influence Human Neoplasia
Peter J. Bugelski et al.
INTERNATIONAL JOURNAL OF TOXICOLOGY (2010)
An Evaluation of Chronic 6-and 12-Month Rat Toxicology Studies as Predictors of 2-Year Tumor Outcome
M. V. Reddy et al.
VETERINARY PATHOLOGY (2010)
Immunomodulator agent-related lymphoproliferative disorders
Robert P. Hasserjian et al.
MODERN PATHOLOGY (2009)
A Data-Based Assessment of Alternative Strategies for Identification of Potential Human Cancer Hazards
Alan R. Boobis et al.
TOXICOLOGIC PATHOLOGY (2009)
IPCS framework for analyzing the relevance of a cancer mode of action for humans
Alan R. Boobis et al.
CRITICAL REVIEWS IN TOXICOLOGY (2006)
Overview: Using mode of action and life stage information to evaluate the human relevance of animal toxicity data
J Seed et al.
CRITICAL REVIEWS IN TOXICOLOGY (2005)
Human carcinogenic risk evaluation: An alternative approach to the two-year rodent bioassay
SM Cohen
TOXICOLOGICAL SCIENCES (2004)
Prediction of rodent carcinogenesis: An evaluation of prechronic liver lesions as forecasters of liver tumors in NTP carcinogenicity studies
DG Allen et al.
TOXICOLOGIC PATHOLOGY (2004)
IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis
C Sonich-Mullin et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2001)